US Stock MarketDetailed Quotes

NRBO NeuroBo Pharmaceuticals

Watchlist
  • 3.8100
  • -0.1100-2.81%
Close Jun 14 16:00 ET
  • 3.9800
  • +0.1700+4.46%
Post 17:47 ET
18.69MMarket Cap-1165P/E (TTM)

NeuroBo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NeuroBo Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-1.32

+67.65%
Analyst Rating

Buy

May 8, 2024

NeuroBo Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2021/Q30.000 / 0.000--
--2021/Q20.000 / 0.000--
--2021/Q10.000 / 0.000--
--2020/Q40.000 / 0.000--
--2020/Q30.000 / 0.000--
--2020/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2021/Q30.000 / 0.000--
--2021/Q20.000 / 0.000--
--2021/Q10.000 / 0.000--
--2020/Q40.000 / 0.000--
--2020/Q30.000 / 0.000--
--2020/Q20.000 / 0.000--

Unlock Free Earnings Estimates

NeuroBo Pharmaceuticals Earnings Reports

  • NeuroBo Pharmaceuticals | 10-Q: Quarterly report

    May 9 09:02 ET

  • NeuroBo Pharmaceuticals | 10-K: Annual report

    Mar 28 22:26 ET

  • NeuroBo Pharmaceuticals: Q3 2023 Earnings Report

    Nov 13, 2023 16:29 ET

  • NeuroBo Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 9, 2023 16:37 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 8, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg